🔬 #ESMO26 | #GIOncology From RAS-targeted therapies to evolving immunotherapy strategies, key trials addressing clinically relevant questions across GI cancers. Great to contribute to this Top 10 selection with my colleagues from the @OncoAlert GI Faculty! 🚀 See you soon!